Skip to content
Physician-backed infrastructure for aesthetic & wellness practicesSupport 9 AM–5 PM EST ·(888) 996-6173 ·info@medgrid.com
MedGrid
Book Free Consult
FDA Daily

FDA daily for Tuesday, October 6, 2026

84 FDA records across 4 sections. 8 touch MedGrid's categories and are listed first.

84FDA Records
4 of 7Sections With Data
8Touch MedGrid Categories

Sections in This Issue

Drug shortagesCovers FDA's Mon, Oct 5 (yesterday)
6 touch MedGrid57
  • Lidocaine Hydrochloride InjectionTouches MedGrid categories

    Lidocaine Hydrochloride, Injection, 100 mg/10 mL (NDC 83634-651-10) — Anthea Pharma

    Reverified · Current · Anesthesia

  • Lidocaine Hydrochloride InjectionTouches MedGrid categories

    Lidocaine Hydrochloride, Injection, 20 mg/2 mL (NDC 83634-653-02) — Anthea Pharma

    Reverified · Current · Anesthesia

  • Lidocaine Hydrochloride InjectionTouches MedGrid categories

    Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05) — Anthea Pharma

    Reverified · Current · Anesthesia

  • Lidocaine Hydrochloride InjectionTouches MedGrid categories

    Lidocaine Hydrochloride, Injection, 200 mg/20 mL (NDC 83634-651-20) — Anthea Pharma

    Reverified · Current · Anesthesia

  • Lidocaine Hydrochloride InjectionTouches MedGrid categories

    Lidocaine Hydrochloride, Injection, 500 mg/50 mL (NDC 83634-651-50) — Anthea Pharma

    Reverified · Current · Anesthesia

  • Lidocaine Hydrochloride InjectionTouches MedGrid categories

    Lidocaine Hydrochloride, Injection, 300 mg/30 mL (NDC 83634-653-30) — Anthea Pharma

    Reverified · Current · Anesthesia

  • Dexamethasone Sodium Phosphate Injection

    Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12) — Mylan Institutional, a Viatris Company

    Reverified · Current · Dermatology

  • Dexmedetomidine Hydrochloride Injection

    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02) — Mylan Institutional, a Viatris Company

    Reverified · Current · Anesthesia

  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 42806-344-01) — Epic Pharma, LLC

    Reverified · Current · Psychiatry

  • Lisdexamfetamine Dimesylate Capsule

    Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77) — Mylan Pharmaceuticals Inc., a Viatris Company

    Reverified · Current · Psychiatry

  • Dexmedetomidine Hydrochloride Injection

    Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 100 mL (NDC 70121-1389-1) — Amneal Pharmaceuticals

    Reverified · Current · Anesthesia

  • Lisdexamfetamine Dimesylate Capsule

    Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77) — Mylan Pharmaceuticals Inc., a Viatris Company

    Reverified · Current · Psychiatry

Showing 12 of 57. Search the rest in openFDA.

Drug approvalsCovers FDA's Tue, Sep 29 (a week ago)
16
  • EYDENZELT

    AFLIBERCEPT-BOAV — CELLTRION INC

    BLA761377 · Labeling

  • PONLIMSI

    DENOSUMAB-ADET — TEVA PHARMACEUTICALS, INC.

    BLA761385 · SUPPL

  • DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER

    DEXTROSE, SODIUM CHLORIDE — B BRAUN

    NDA019631 · Labeling

  • AVTOZMA

    TOCILIZUMAB-ANOH — CELLTRION INC

    BLA761420 · SUPPL

  • TRANEXAMIC ACID

    TRANEXAMIC ACID — PHARMOBEDIENT

    ANDA201580 · Labeling

  • AVTOZMA

    TOCILIZUMAB-ANOH — CELLTRION INC

    BLA761498 · Labeling

  • RIFAMPIN

    RIFAMPIN — FRESENIUS KABI USA

    ANDA091181 · Labeling

  • RIABNI

    RITUXIMAB-ARRX — AMGEN INC

    BLA761140 · Bioequivalence

  • AZITHROMYCIN

    AZITHROMYCIN — EUGIA PHARMA

    ANDA203294 · Labeling

  • FENOFIBRATE (MICRONIZED)

    FENOFIBRATE — SUN PHARM INDS LTD

    ANDA201748 · Labeling

  • CELECOXIB

    CELECOXIB — CSPC OUYI

    ANDA210071 · Labeling

  • CLOZAPINE

    CLOZAPINE — AUROBINDO PHARMA

    ANDA206433 · Labeling

Showing 12 of 16. Search the rest in openFDA.

Drug recallsCovers FDA's Tue, Sep 29 (a week ago)
Nothing from FDA for this date
Food and supplement recallsCovers FDA's Tue, Sep 29 (a week ago)
Nothing from FDA for this date
Device recallsCovers FDA's Tue, Sep 29 (a week ago)
Nothing from FDA for this date
Device clearancesCovers FDA's Tue, Sep 22 (two weeks ago)
2 touch MedGrid9
  • Instant-View® hCG Combo II Cassette TestTouches MedGrid categories

    Alfa Scientific Designs, Inc.

    K262299 · Substantially Equivalent · Clinical Chemistry

  • Multiple therapy aesthetic treatment device (BHS 202 UNYQUE)Touches MedGrid categories

    Bh Group Us, LLC

    K243223 · Substantially Equivalent · General, Plastic Surgery

  • Echo-2

    Neko Health AB

    K254240 · Substantially Equivalent · Cardiovascular

  • ErgoSteel (ES0001/696)

    Strongback Mobility AG C/O Blueaudit GmbH

    K253762 · Substantially Equivalent · Physical Medicine

  • BIOFIRE Respiratory Panel 2.1 (RP2.1)

    Biofire Diagnostics

    K263054 · Substantially Equivalent · Microbiology

  • Actolind® (06.3637. Actolind® Gel Plus)

    ACTO GmbH

    K254168 · Substantially Equivalent · Unknown

  • BoneXpert

    Visiana

    K262390 · Substantially Equivalent · Radiology

  • BodyTom 64 (NL4100); OmniTom Elite (NL5000)

    Samsung HME America, Inc., dba NeuroLogica Corp.

    K261125 · Substantially Equivalent · Radiology

  • HipStudio Analysis

    Replasia BV

    K262442 · Substantially Equivalent · Radiology

Label changesCovers FDA's Tue, Sep 22 (two weeks ago)
2
  • Drug label

    Label version 3

  • leader clearlax

    Cardinal Health 110, LLC. dba Leader

    Label version 7

How the FDA Daily Is WrittenSources, dates and what gets flagged

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug recalls, device recalls and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Items that touch the categories MedGrid works in, such as GLP-1s, hormones, injectables, peptides, compounded products and aesthetic devices, are marked and listed first.

Subscribe with any feed reader, or point an email tool at theRSS feed. For the rules behind the headlines, see Regulations Research.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.